R Du Toit
About
In The Last Decade
R Du Toit
26 papers receiving 418 citations
Peers
Comparison fields: 5 of 70
- Epidemiology 89
- Infectious Diseases 88
- Rheumatology 81
- Obstetrics and Gynecology 77
- Surgery 76
Countries citing papers authored by R Du Toit
This map shows the geographic impact of R Du Toit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Du Toit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Du Toit more than expected).
Fields of papers citing papers by R Du Toit
This network shows the impact of papers produced by R Du Toit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Du Toit. The network helps show where R Du Toit may publish in the future.
Co-authorship network of co-authors of R Du Toit
This figure shows the co-authorship network connecting the top 25 collaborators of R Du Toit. A scholar is included among the top collaborators of R Du Toit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Du Toit. R Du Toit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 8 | |
| 7 | 13 | |
| 8 | 6 | |
| 9 | 0 | |
| 10 | 15 | |
| 11 | 9 | |
| 12 | 17 | |
| 13 | 12 | |
| 14 | 5 | |
| 15 | Laboratory experience and guidelines for avoiding false positive polymerase chain reaction results. | 33 |
| 16 | No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers. | 84 |
| 17 | 14 | |
| 18 | Conservative management of severe proteinuric hypertension before 28 weeks' gestation. | 29 |
| 19 | Frequent fetal heart-rate monitoring for early detection of abruptio placentae in severe proteinuric hypertension. | 10 |
| 20 | Fetal and neonatal outcome in patients with severe pre-eclampsia before 34 weeks. | 41 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.